Please provide your email address to receive an email when new articles are posted on . Older patients with atrial fibrillation were more likely to have high bleeding risk contraindications with oral ...
An analysis of the ongoing SAGE-AF trial revealed that approximately 23% of geriatric patients with atrial fibrillation and prescribed a direct oral anticoagulant received inappropriate dosing. Most ...
It is uncommon for hospitalized older adults newly diagnosed with atrial fibrillation to start anticoagulation therapy. In fact, only about 25% overall begin taking these medications soon after ...
Most patients with pulmonary embolism (i.e., low-risk, intermediate–low-risk, and most intermediate–high-risk) are adequately managed with anticoagulation alone. Selected intermediate–high-risk ...
Anticoagulant or antiplatelet drugs, sometimes called blood thinners, help prevent blood clots. There are many options, including heparin and warfarin. Preventing clots reduces the risk of stroke and ...
With more than 15 years of evidence and the continuing evolution of devices, the Society for Cardiovascular Angiography and Interventions (SCAI) and the Heart Rhythm Society (HRS) have released ...
New information has become available to help guide clinicians on the thorny issue of oral anticoagulation in patients with atrial fibrillation (AF) who have had an intracranial hemorrhage (ICH). The ...
Effect of Transfemoral Aortic Valve Implantation on Plasma Brain Natriuretic Peptide Levels and Its Predictive Value for 30-day and 1-year survival Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback